换一批
换一批Combination of docetaxel and TSU-68, an oral antiangiogenic agent, in patients with metastatic breast cancer previously treated with anthracycline: randomized phase II multicenter trial.
作者：
主题词
成年人(Adult);老年人(Aged);血管生成抑制剂(Angiogenesis Inhibitors);蒽环类(Anthracyclines);抗肿瘤药(Antineoplastic Agents);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);乳腺肿瘤(Breast Neoplasms);无病生存(Disease-Free Survival);女(雌)性(Female);人类(Humans);吲哚类(Indoles);中年人(Middle Aged);丙酸盐类(Propionates);吡咯类(Pyrroles);紫杉烷类(Taxoids)
DOI
10.1007/s10637-014-0093-6
PMID
24715580
发布时间
2021-12-03
- 浏览36
Investigational new drugs
753-61页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
